News from Cytos A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

03 Dec, 2015, 01:00 ET Cytos Biotechnology and Kuros Biosurgery to Combine to Create Kuros Biosciences

  - Combined company aims to be a leader in the field of tissue repair and regeneration  - Late-stage clinical pipeline of...


30 Dec, 2013, 08:30 ET Extraordinary Shareholders' Meeting of Cytos Biotechnology Ltd: Shareholders Approve all Resolutions

Cytos Biotechnology Ltd (SIX:CYTN) today announced that its shareholders have approved all resolutions at the Extraordinary Shareholders'...


04 Feb, 2013, 01:45 ET Cytos VLP Platform is Basis for Phase 1 Clinical Trial with Anti-IgE Vaccine

Cytos Biotechnology Ltd (SIX:CYTN) has been informed by Pfizer Inc. that the first patient has been dosed in a Phase 1 clinical trial with an...


04 Feb, 2013, 01:00 ET Cytos VLP Platform is Basis for Phase 1 Clinical Trial with Anti-IgE Vaccine

 Cytos Biotechnology Ltd (SIX:CYTN) has been informed by Pfizer Inc. that the first patient has been dosed in a Phase 1 clinical trial with an...


23 Jan, 2013, 01:17 ET Cytos to Regain Rights to Smoking Cessation Vaccine

Cytos Biotechnology Ltd (SIX:CYTN) today announced that Novartis will discontinue the NIC002 project, which is a therapeutic vaccine...


16 Jan, 2013, 01:05 ET Cytos Provides Update of Phase 2b Clinical Trial of CYT003 in Allergic Asthma

Cytos Biotechnology Ltd (SIX:CYTN) today announced an update on the Phase 2b clinical trial with its lead product candidate, CYT003, in allergic...